.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Moodys
Queensland Health
Harvard Business School
Cerilliant
Federal Trade Commission
US Army
Covington
Chubb

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076842

« Back to Dashboard

NDA 076842 describes HYDROCORTISONE BUTYRATE, which is a drug marketed by Glenmark Generics, Taro Pharm Inds, and Taro, and is included in four NDAs. It is available from two suppliers. Additional details are available on the HYDROCORTISONE BUTYRATE profile page.

The generic ingredient in HYDROCORTISONE BUTYRATE is hydrocortisone butyrate. There are sixty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.

Summary for 076842

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 076842

Suppliers and Packaging for NDA: 076842

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROCORTISONE BUTYRATE hydrocortisone butyrate OINTMENT;TOPICAL 076842 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4083 51672-4083-1 1 TUBE in 1 CARTON (51672-4083-1) > 15 g in 1 TUBE
HYDROCORTISONE BUTYRATE hydrocortisone butyrate OINTMENT;TOPICAL 076842 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4083 51672-4083-7 1 TUBE in 1 CARTON (51672-4083-7) > 10 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.1%
Approval Date:Dec 27, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Julphar
Chinese Patent Office
Fish and Richardson
Cerilliant
Cantor Fitzgerald
Merck
Novartis
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot